Dronedarone and Atrial Fibrillation: A Critical Review

David Singh; Eugenio Cingolani; Sanjay Kaul; Steven Singh

JOURNAL

Clinical Medicine Reviews in Vascular Health

Dronedarone and Atrial Fibrillation: A Critical Review

Submit a Paper

David Singh, Eugenio Cingolani, Sanjay Kaul and Steven Singh

Clinical Medicine Reviews in Vascular Health 2010:2

Review

Published on 20 Jul 2010

DOI: 10.4137/CMRVH.S4703

Further metadata provided in PDF

Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Vascular Health

Abstract and Sharing
Article Metrics
Discuss

Abstract

The recent approval of dronedarone by the Food and Drug Administration has expanded the list of drugs available for the treatment of atrial fibrillation (AF). Despite wide-spread attention, the future of this antiarrhythmic compound remains uncertain. The aim of this review is to examine the major clinical trials that have evaluated dronedarone in human subjects and provide a practical framework for its use among patients with AF.

Downloads

RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation (BIBDESK, LATEX)

What Your Colleagues Say About Clinical Medicine Reviews in Vascular Health

Publishing in Clinical Medicine Reviews in Vascular Health was a pleasant experience. The process was fast and fair. The staff were very professional and we were well informed of the progress of the manuscript.

Dr Abd A Tahrani MD (Birmingham Heartlands Hospital, University of Birmingham, UK)

More Testimonials